Beam Therapeutics Inc. (BMV:BEAM)
Mexico
· Delayed Price · Currency is MXN 392.00
0.00 (0.00%)
At close: Apr 29, 2025
Beam Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | -376.74 | -132.53 | -289.09 | -370.64 | -194.59 | Upgrade
|
| Depreciation & Amortization | 21.93 | 20.01 | 14.15 | 7.45 | 4.74 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 154.95 | 5.65 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.67 | -11.15 | -29.61 | -17.77 | -0.4 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 25.5 | - | - | Upgrade
|
| Stock-Based Compensation | 120.66 | 98.65 | 84.32 | 43.57 | 15.38 | Upgrade
|
| Other Operating Activities | 5.8 | -7.72 | -34.37 | 4.91 | 68.14 | Upgrade
|
| Change in Accounts Receivable | - | -0.15 | 300 | -300 | - | Upgrade
|
| Change in Accounts Payable | 1.81 | -7.58 | 2.37 | 0.82 | 0.06 | Upgrade
|
| Change in Unearned Revenue | -36.52 | -159.56 | -35.92 | 348.16 | - | Upgrade
|
| Change in Other Net Operating Assets | -75.51 | 50.83 | -14.83 | 62.28 | 5.29 | Upgrade
|
| Operating Cash Flow | -347.25 | -149.2 | 22.53 | -66.27 | -95.74 | Upgrade
|
| Capital Expenditures | -8.95 | -33.73 | -48.95 | -46.81 | -16.36 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.62 | -0.75 | Upgrade
|
| Investment in Securities | 193.95 | 105.57 | -412.39 | -247.95 | -83.02 | Upgrade
|
| Investing Cash Flow | 185.01 | 71.84 | -461.34 | -294.14 | -100.12 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3.27 | Upgrade
|
| Long-Term Debt Repaid | -0.49 | -2.25 | -2.29 | -2.12 | -1.57 | Upgrade
|
| Net Debt Issued (Repaid) | -0.49 | -2.25 | -2.29 | -2.12 | 1.7 | Upgrade
|
| Issuance of Common Stock | 8.22 | 279.33 | 114.07 | 767.08 | 322.68 | Upgrade
|
| Other Financing Activities | - | -0.63 | -0.19 | -8.82 | -2.06 | Upgrade
|
| Financing Cash Flow | 7.74 | 276.45 | 111.59 | 756.14 | 322.32 | Upgrade
|
| Net Cash Flow | -154.5 | 199.09 | -327.22 | 395.73 | 126.46 | Upgrade
|
| Free Cash Flow | -356.19 | -182.93 | -26.42 | -113.08 | -112.1 | Upgrade
|
| Free Cash Flow Margin | -560.77% | -48.43% | -43.38% | -218.11% | -467075.00% | Upgrade
|
| Free Cash Flow Per Share | -4.33 | -2.37 | -0.38 | -1.76 | -2.40 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.16 | 0.38 | 0.57 | 0.56 | Upgrade
|
| Levered Free Cash Flow | -156.52 | -50.36 | 138.32 | -335.34 | -12.67 | Upgrade
|
| Unlevered Free Cash Flow | -156.52 | -50.36 | 138.32 | -335.34 | -12.67 | Upgrade
|
| Change in Net Working Capital | 30.43 | 24.98 | -300.35 | 191.1 | -66.55 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.